Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudomonas aeruginosa virulence and motility machinery refers to the collective set of molecular mechanisms that enable this opportunistic pathogen to colonize hosts, evade immune responses, and cause tissue damage. This machinery includes the Type III Secretion System (T3SS), which delivers effector toxins directly into host cells, and complex quorum sensing (QS) circuits (Las, Rhl, and PQS systems) that regulate the expression of extracellular proteases and pigments like pyocyanin (Hauser, 2009; Lee & Zhang, 2015). Additionally, the bacterium utilizes flagella for swimming and Type IV pili for twitching motility, both of which are essential for the initial stages of biofilm formation and surface attachment (Burrows, 2012). Because these systems are vital for pathogenesis but often non-essential for basic bacterial growth, they are prime targets for anti-virulence therapies designed to reduce disease severity without driving the rapid development of antibiotic resistance (Dickey et al., 2017). Therapeutic approaches currently under investigation include the use of QS inhibitors, T3SS blockers, and iron-chelating agents to disrupt the bacterium's ability to thrive and disseminate within the host environment.
Inhibition of quorum sensing (QS) signaling pathways, blockade of the Type III Secretion System (T3SS) needle complex or effector translocation, disruption of flagellar and Type IV pili assembly, and sequestration of essential nutrients such as iron to prevent bacterial colonization and tissue damage.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa virulence and motility machinery.